Livzon Pharma Confirms RMB1.10 Billion Q3 Dividend, Shareholder Return Plan and Adds New Non-Executive Director

Bulletin Express
11/12

Livzon Pharmaceutical Group Inc. (Livzon Pharma, HKEX: 01513) has secured shareholder approval for three key ordinary resolutions at its Second Extraordinary General Meeting (EGM) held on 12 November 2026 in Zhuhai, Guangdong.

Dividend Distribution • Shareholders endorsed a third-quarter cash dividend of RMB 12.39 (tax inclusive) per 10 shares, equivalent to RMB 1.239 per share. • The payout totals RMB 1.10 billion. • A-share holders on record after trading hours of 24 November 2026 will receive the dividend in RMB. • H-share holders on record at the close of 26 November 2026 will be paid in Hong Kong dollars at an exchange rate of HK$1 = RMB 0.85633, translating to approximately HK$14.47 per 10 H Shares. • Dividend cheques are scheduled for dispatch on or before 23 December 2026 via the company’s paying agent, Industrial and Commercial Bank of China (Asia) Limited. • Withholding tax will be applied at 20 % for overseas individual investors and 10 % for non-resident enterprise shareholders, in accordance with PRC tax regulations. Domestic investors under Southbound Trading Link will follow prevailing policies.

Board Changes • Ms Zhu Linlin has been appointed as Non-Executive Director, effective immediately and co-terminous with the current 12th Board session. The Board continues to comprise two executive directors, three non-executive directors (including Ms Zhu), one employee representative director and four independent non-executive directors.

Shareholder Participation and Voting • The EGM drew 540 shareholders and proxies representing 433.09 million shares, or 48.78 % of Livzon Pharma’s 887.91 million issued shares. • All three resolutions—director appointment, Q3 profit distribution plan, and the 2026-2028 shareholder return plan—passed with support exceeding 98 % of votes cast. Grant Thornton (Special General Partnership) acted as scrutineer, and Guangdong Chongli Law Firm affirmed the legality of the meeting and its outcomes.

Key Dates for H-Shareholders • Last day to trade cum-dividend: 24 November 2026 • Ex-dividend date: 25 November 2026 • Record date: 26 November 2026

The company will issue a separate notice outlining dividend payment arrangements for A-share investors.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10